We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
3451
Tempest Therapeutics
TPST
$16.1M
$20K ﹤0.01%
665
+158
+31% +$3.46K
TR icon
3452
Tootsie Roll Industries
TR
$3.08B
$20K ﹤0.01%
480
+190
+66% +$7.58K
UMH
3453
UMH Properties
UMH
$1.4B
$20K ﹤0.01%
1,360
-700
-34% -$11.5K
UVE icon
3454
Universal Insurance Holdings
UVE
$1.2B
$20K ﹤0.01%
1,082
-2,006
-65% -$29.7K
UWMC icon
3455
UWM Holdings
UWMC
$2.55B
$20K ﹤0.01%
3,972
-1,208
-23% -$5.3K
VNDA icon
3456
Vanda Pharmaceuticals
VNDA
$316M
$20K ﹤0.01%
2,894
+2,351
+433% +$16.5K
VPG icon
3457
Vishay Precision Group
VPG
$969M
$20K ﹤0.01%
468
-214
-31% -$9.04K
ZGN icon
3458
Zegna
ZGN
$3.69B
$20K ﹤0.01%
1,485
+436
+42% +$5.39K
AAMI
3459
Acadian Asset Management
AAMI
$3.28B
$20K ﹤0.01%
862
+516
+149% +$12.1K
TVRD
3460
Tvardi Therapeutics
TVRD
$23.7M
$20K ﹤0.01%
116
-376
-76% -$126K
INST
3461
DELISTED
Instructure Holdings, Inc.
INST
$20K ﹤0.01%
772
+408
+112% +$10.5K
HLTH
3462
DELISTED
Cue Health Inc. Common Stock
HLTH
$20K ﹤0.01%
10,781
+6,999
+185% +$15.2K
SP
3463
DELISTED
SP Plus Corporation
SP
$20K ﹤0.01%
571
+257
+82% +$9.11K
KNTE
3464
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$20K ﹤0.01%
3,094
+2,406
+350% +$14.7K
ALHC icon
3465
Alignment Healthcare
ALHC
$2.9B
$19K ﹤0.01%
2,931
+2,089
+248% +$19.9K
ALX
3466
Alexander's
ALX
$1.38B
$19K ﹤0.01%
97
+57
+143% +$12.3K
AMBP icon
3467
Ardagh Metal Packaging
AMBP
$3.13B
$19K ﹤0.01%
4,500
-21,818
-83% -$107K
AMPL icon
3468
Amplitude
AMPL
$1.63B
$19K ﹤0.01%
1,496
-8
-0.5% -$106
ANAB icon
3469
AnaptysBio
ANAB
$1.73B
$19K ﹤0.01%
862
+433
+101% +$10.5K
ARIS
3470
DELISTED
Aris Water Solutions
ARIS
$19K ﹤0.01%
2,383
+2,229
+1,447% +$28.7K
BBAR icon
3471
BBVA Argentina
BBAR
$3.13B
$19K ﹤0.01%
4,781
-889
-16% -$3.98K
BKKT icon
3472
Bakkt Inc
BKKT
$342M
$19K ﹤0.01%
449
+12
+3% +$467
BLFY
3473
DELISTED
Blue Foundry Bancorp
BLFY
$19K ﹤0.01%
2,043
+184
+10% +$2.11K
BRSP
3474
BrightSpire Capital
BRSP
$633M
$19K ﹤0.01%
3,198
+543
+20% +$3.72K
BUR icon
3475
Burford Capital
BUR
$960M
$19K ﹤0.01%
1,681
+236
+16% +$1.96K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.